A phase I/II study of leucovorin, carboplatin and 5-fluorouracil (LCF) in patients with carcinoma of unknown primary site or advanced oesophagogastric/pancreatic adenocarcinomas.

Carcinoma of unknown primary site (CUPS) accounts for 5-10% of all malignancies. Forty patients with metastatic CUPS or advanced oesophagogastric/pancreatic adenocarcinomas were recruited. Eligibility included ECOG performance status 0-2, minimum life expectancy of 3 months and measurable disease. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Rigg, A., Cunningham, D., Gore, M., Hill, M., O'Brien, M., Nicolson, M., Chang, J., Watson, M., Norman, A., Hill, A., Oates, J., Moore, H., Ross, P.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2222694/
https://www.ncbi.nlm.nih.gov/pubmed/9000605

Ejemplares similares

Ejemplares similares